Globus Medical to debut SCRIPT implant platform at NASS 2026

Globus Medical will preview its FDA-cleared SCRIPT patient-specific spinal implant platform and a new prone lateral procedural solution at NASS in San Antonio.

Globus Medical to debut SCRIPT implant platform at NASS 2026

Globus Medical (NYSE: GMED) will use the 41st Annual North American Spine Society (NASS) Meeting in San Antonio, Texas, running 14–17 October, to showcase two additions to its integrated spine portfolio: the SCRIPT patient-specific spinal implant platform and the XLIF Prone Procedural Solution.

The Audubon, Pennsylvania-based company describes its strategy as building a connected surgical ecosystem in which preoperative planning, implant selection, patient positioning, and intraoperative navigation are linked across a single workflow. The NASS showcasing represents the company's most public step yet toward commercialising that vision.

SCRIPT: patient-specific planning meets navigated execution

SCRIPT is Globus Medical's entry into patient-specific spinal implants, a category in which surgeon-facing planning software generates bespoke implant geometry ahead of an operation. Within what the company calls SCRIPT Studio, surgeons configure alignment, implant position, and fixation strategy before the procedure. Those plans can then be imported into the company's ExcelsiusGPS or ExcelsiusHub navigation platforms, connecting the preoperative blueprint with a real-time navigated workflow in the operating room.

The technology has received FDA clearance. Globus Medical says it is moving toward full commercialisation and is offering an exclusive preview at its technology suite at booth 315 during the conference.

Keith Pfeil, President and Chief Executive, said the company's focus is on "developing an integrated ecosystem that helps surgeons translate their surgical plan in the operating room while supporting the clinical needs of each individual patient." The release does not provide clinical data, outcome metrics, or details on procedure volumes anticipated at launch.

XLIF Prone Procedural Solution: prone lateral access refined

The second major highlight is the XLIF Prone Procedural Solution, which combines the XLIF Prone Patient Positioner with the MaXcess Air two-blade retractor. Prone lateral access, in which a patient lies face-down rather than in the traditional lateral decubitus position, has grown in use among spine surgeons seeking to combine lateral disc access with posterior correction in a single position change. The technique can reduce operative time and avoid repositioning, but it demands specialised positioning equipment and retractor systems adapted to the altered anatomy.

Globus Medical says its positioner allows adjustment in both the sagittal and coronal planes, offering intraoperative flexibility, while the MaXcess Air retractor is designed as a lightweight rigid platform to manage soft tissue and maintain stable disc-space access. No comparative data against existing prone lateral systems are provided in the release.

Market context and competitive landscape

The spine technology sector is increasingly defined by the race to integrate enabling technologies, including robotics, navigation, augmented reality, and patient-specific implants, within single-vendor workflows. Globus Medical competes in this space against Medtronic's Mazor-based robotic platform, Stryker's Spine division, Zimmer Biomet, and NuVasive, which merged with Globus Medical's former parent group. The patient-specific implant segment in spine remains smaller than its orthopaedic counterpart in hips and knees, but demand is rising as imaging and additive manufacturing costs fall.

Analysts following GMED will be watching for commercialisation timelines, pricing strategy, and early surgeon adoption data for SCRIPT, given that the platform's value proposition depends heavily on workflow integration with ExcelsiusGPS, a navigation system already in use at a number of surgical centres. The XLIF Prone solution extends an existing product family and is likely to face a faster adoption curve among surgeons already familiar with the XLIF approach.